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THE GENETIC AMYLOIDOSES WITH SPECIAL EMPHASIS ON
FAMILIAL MEDITERRANEAN FEVER"^
EZRA SOHAR, M.D.**

I T IS A GREAT pleasure to talk about Famihal Mediterranean Fever (FMF) here in
Detroit where the disease is familiar to physicians. Therefore, I will not go into
details about the clinical picture of the disease, which I trust you know as well as
we. I shall talk about F M F as one of the genetic amyloidoses and stress in passing
only those clinical aspects which apparently are more obvious in Israel.
By way of introduction, I would like to say a word about the incidence of
amyloidosis. Usually considered a rare disease, it has been reported in between 0.5
to 0.8 per cent of autopsies. However, we have recently taken blocks of 200 consecutive autopsies at our hospital, in which amyloidosis was not diagnosed, and
among these found amyloid deposits in 28 including two cases of generalized amyloidosis. I would also like to recall the experience of Dr. Teilum, Professor of
Pathology in Copenhagen.= On reviewing, from his own department, 28 autopsied
cases of rheumatoid arthritis in whom the diagnosis of amyloidosis had been made
in only 3 he found amyloid in 14 additional ones. This proves that amyloid is not
just found; it must be looked for, and when looked for, it is not so rare after all.
The true incidence of amyloidosis is certainly much higher than has been suspected.
One reason we found more cases than usual is a technique which we learned
from Dr. Hans-Peter Missmahl of Tubingen, Germany." This calls for the staining of
amyloid tissue by Congo red and examining with the polarized-hght microscope. With
this technique, we frequently were able to identify with certainty amyloid deposits
not detectable by ordinary microscopy and thus to establish the diagnosis of amyloidosis.
This was of special help in the examination of biopsy material.
When a physician thinks or speaks about amyloidosis he usually conceives of
it as being secondary to some chronic infectious or inflammatory disease. When we
encountered our first F M F patient with amyloidosis, it seemed logical to assume
that the amyloidosis was secondary to the many attacks of fever he had suffered.
*Presented before the Henry Ford Hospital Tuesday Morning Medical Staff Meeting, March 3, 1964.
Supported in part by USPHS, National Institutes of Health Research Grant A-2857.
**Tel-Hashomer Hospital, Clinical Research Laboratory, FMF Unit, Israel.
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However, it was not long before amyloidosis was found in another patient very shortly
after the onset of his attacks, and finally our experience broadened to include a
patient who had never had attacks (his brother suffered from attacks) and in whom
amyloidosis appeared as the sole manifestation of FMF. These observations led to
the conclusion that the amyloidosis in FMF is not secondary but hereditary.
There are today five entities of genetic amyloidosis and it is likely that in the
future additional entities will be described. This morning I shall review the genetic
amyloidoses described so far and suggest some sort of classification.
The inherited amyloidoses are systemic involving all organs of the body with
few exceptions. Nevertheless, the disease usually becomes manifest clinically through
the more massive involvement of one organ. Accordingly, they can be divided
into three types: the nephropathic types in which the main symptoms and signs arc
those of renal disease; the neuropathic forms in which peripheral neuropathy is the
principal feature; the cardiopathic type which is marked by intractable heart failure.
I shall start with F M F which is a nephropathic amyloidosis. F M F is an
ethnically restricted disease. As you know, the Jewish population is divided in its
ethnic origin into Ashkenazi and Sephardi Jews. In Israel, each of these groups
comprises about 50 per cent of the population. Nevertheless, our 400 patients include
only nine Ashkenazi, all the others being Sephardi Jews who derive from various
countries around the Mediterranean; there are five Arabs, all born in Israel. It is
not so astonishing that most of our patients in Israel are Jews. However, a review
of the literature will show that the largest group (more than 50 per cent) are again
non-Ashkenazi Jews; the remainder include a large group of Armenians, a small group
of Arabs and sporadic cases of other origins. A l l of them derive from Mediterranean
countries.
A disease which is ethnically restricted, unless it is due to some infectious or
nutritional factor, is usually a genetic disease. In F M F we have shown that the
disease is transmitted as a complete autosomal recessive. A positive family history
was obtained in 229 of 400 patients and a questionable one in 75. In the vast
majority of cases only sibs are affected, and we find that of 215 marriages producing
FMF offspring, 42 were cousin marriages. Thus, we find all the characteristics of
recessive inheritance, as has also been shown by other techniques. The gene frequency
is 0.02 in the Sephardi Jewish population.
FMF becomes clincially manifest very early in life. By the age of 15, about
two-thirds of the patients are already affected and by the age of 20, more than 30
per cent. It seems likely that most of the remainder probably experience some sort
of attacks in childhood, but the disease is not recognized at that time. It is of
interest to note that our youngest patient developed his first attack when one month old.
The attacks of F M F consist of short bouts of fever accompanied by abdominal
pain, by chest pain or by joint manifestations. Although attacks as a rule subside in
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24-48 hours, we have observed rather frequently the protraction of a usual joint
attack into a chronic monoarthritis, which may persist for weeks and even months.
It is a characteristic feature of the arthritis of F M F that even if the patient develops
hydroarthrosis and is immobilized for weeks or months, the inflammatory changes
eventually resolve and the patient regains complete use of his joints. Another feature
which I believe is characteristic of F M F is a skin manifestation which we call
erysipslas-like erythema. It usually appears in the ankle region, frequently after
strenuous exercise, and subsides in 12 to 24 hours.
As to the amyloidosis, we have examined 330 patients. Of these, 53 have died
of amyloidosis while 50 are living today with nephropathy; in 23 of the later amyloid
has been demonstrated by rectal biopsy.''^'^
The duration of the nephropathy from the time of diagnosis to death is usually
6 to 10 years. There is a large group who died earlier, but these came under
observation when they already had progressive renal disease. We know today that
there is a pre-clinical stage of amyloidosis. In one of our patients kidney biopsy was
performed and found positive for amyloid, in spite of the fact that she presented
no clinical or laboratory evidence of renal disease or other manifestations of amyloidosis.
Three years passed from the time of biopsy to the appearance of proteinuria. There
is, therefore, a prolonged pre-clinical stage in amyloidosis of F M F and probably in
the others as well.
Most of our patients are very young. Two-thirds are below the age of 30,
80 percent below 35. The age of death from amyloidosis is also very ea.rly.
youngest patient was six years old when he died. It is interesting to note that
cause of death in all of our F M F patients was amyloidosis, except for one who
killed in a road accident.
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We now have five patients who have never shown attacks of F M F prior to the
appearance of amyloidosis. However, each of them has a sibling or offspring who
shows classical F M F attacks. We believe that there are two phenotypes of F M F :
Phenotype I , in which attacks precede the onset of amyloidosis and phenotype I I ,
in which amyloidosis appears first and clinical attacks appear later or not at all.
A few years ago, Drs. Muckle and Wells' from England described a family in
which 9 of 18 members in three generations were affected by a curious disease
characterized by bouts of fever, urticarial skin rash, progressive deafness and renal
disease due to a.myloidosis. The transmission in this family was a dominant one,
death occurring from renal failure between the ages of 40 to 45. This then is the
other example of nephropathic genetic amyloidosis.
A myocardiopathic amyloidosis was described in Denmark last year in a family
in which 8 of 12 siblings were affected. Fatigue, dyspnea and intractable heart failure
appeared between the ages of 40 and 50. The patients died two to five years after
the onset of symptoms. Transmission is probably dominant.
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Two types of neuropathic amyloidosis are known today. One has been described
by various Portugese authors, notably Andrade and Horta,' who have observed to
date more than 100 cases. In those affected, a dominantly transmitted gene causes
severe manifestations leading, after five years, to death. The manifestations are predominantly of a peripheral neuropathy affecting first and most severely the lower
extremities, and later the gastrointestinal tract.
Another form of neuropathy has been reported from America by Rukavina and
his group.' Manifestations start in the upper extremities often with a carpal tunnel
syndrome, and the disease, which is also dominantly transmitted, progresses much
more slowly than the Portugese variety. An interesting and probably pathognomonic
feature is the presence of opacities composed of amyloid material in the vitreous
body of the eye.
An enumeration of the genetic amyloidoses according to their presentation as
nephropathy, cardiopathy or neuropathy is presented in Table I . '
F M F and the Portuguese form of amyloid neuropathy are ethnically restricted.
It is also of interest to note that the cardiopathy and the two neuropathies produce
symptoms which are due exclusively to amyloid deposition in the tissues; whereas,
in the nephropathic forms ( F M F and the syndrome of Muckle and Wells) there are
pleiotropic manifestations of the gene. These are symptoms and signs which are
independent characters of the mutant gene but are not directly related to the formation
of amyloid.
I must say a few words concerning the histology of amyloidosis. We all know,
I am sure, the classical distinctions between typical and atypical amyloidosis, which
assume that typical amyloidosis is of the secondary type and atypical the primary
type. This has been used in various classifications, but in practice it has been shown
that there is no close correlation between primary and atypical on the one hand,
or typical and secondary on the other.
Table I
THE GENETIC AMYLOIDOSES
Clinical
Varieties
NEPHROPATHY
1. Familial Mediterranean Fever
a) Phenotype I :
Attacks first
b) Phenotype I I :
Amyloidosis first

Histological
type

Mode of
inheritance

Ethnic
predilection

Peri-reticulin

Recessive

Mediterranean Jews
and Armenians

2. Fever, rash, and deafness
CARDIOPATHY

Dominant
Peri-collagen

" (?)

NEUROPATHY
1. Legs most affected
2. Arms most affected

Portuguese
None
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We have examined 70 cases of amyloidosis of the various syndromes including
all five genetic entities. This was carried out a short time after Dr. Missmahl
published two cases of amyloidosis in which he claimed that in each the mode of
deposition of amyloid was different histologically. The difference is this: In one
case he found the amyloid deposited close to the lumen of the arterioles, in the
intima and the media, where reticulin fibers are usually very numerous. In the
second he found amyloid mainly in the adventitia where collagen fibers normally
predominate. We examined, as I said, 70 cases with him at our laboratory and
came to the conclusion that not only has every case of amyloidosis either a "perireticulin" or a "peri-collagen" distribution, but also every clinical entity of amyloidosis
is homogeneous in this respect, belonging either to one or the other group.
Amyloidosis is a disease of tissue systems and is not limited to specific organs.
In the one variety, amyloid is deposited throughout the body where reticulin fibers
are numerous; whereas, in the other the collagen fiber is primarily affected.
Fig. 1. is a graphic description of the two varieties. It shows that peri-reticulin
amyloid is initially deposited in the intima and later spreads centrifugally. Pericollagen amyloid is first deposited in the adventitia and spreads centripetally, leaving
the intima free.

PerlReticular
Deposition

PerlCoUaqen
Deposition

Figure 1
The vascular lesion in peri-reticulin and peri-collagen amyloidosis (reproduced from Harefuah
64:41, 1963). (White line behind the arrow indicates site of the initial amyloid deposition.)
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As to the classification of amyloidosis, our suggestion is based upon histological
and etiological criteria (Table I I ) . Of the genetic amyloidoses, two are of peri-reticulin
and three of peri-collagen distribution. Of the various entities of secondary or acquired
amyloidosis, all except that of multiple myeloma and macroglobulinemia are of the
peri-reticulin variety. The idiopathic forms include those cases in which no lesion
other than amyloidosis was found on autopsy, and the etiology is unknown.
We urge that a distinction be made between "primary" and "idiopathic amyloidosis.
Primary should best be an anatomopathological term only, connoting no more than
that amyloidosis is the sole autopsy finding. A case of primary amyloidosis may be
of known or unknown etiology. If it is a genetic amyloidosis, etiology is known
though pathogenesis is not. It is probable that many cases of so-called idiopathic
primary amyloidosis are sporadic examples of the genetic type. In such cases, a
complete family history and evaluation of a pedigree is indicated and sometimes, as
has happened, a genetic amyloidosis will be established.

SUMMARY

The pathogenesis of amyloidosis is still unknown. It has been variously assumed
to be due to antigen-antibody reaction, to various deposits from the blood, and so on.
None of these theories have been proved. I would like to conclude with a few
words regarding our hypothesis on the pathogenesis of amyloidosis, which is based,
mainly on 3 facts:
1) Amyloid occurs throughout the body in connective tissue and has never
been found in any other tissue.
2) Amyloid is a fibrous protein, as has been proved by polarized-light and
electron microscopy.
3) Amyloid is initially deposited in relation to pre-existing connective fibers,
either reticulin or collagen.
Table I I
CLASSIFICATION OF THE AMYLOIDOSES
PERI-RETICULAR

PERI-COLLAGEN

Hereditary

Familial Mediterranean Fever
Urticaria and Deafness (Muckle & Wells)

Neuropathic (Rukavina et al)
Neuropathic (Andrade: Horta)
Cardiopathic (Frederiksen et al)

Acquired

Assoc. with Chronic Infection (tuberculosis,
osteomyelitis, etc.).
Chronic Inflammation of Unknown
Etiology (Rheumatoid arth., etc.).
Malignant Neoplasms

Assoc. with Multiple Myeloma

Idiopathic

Nephropathic ("typical distribution")

"Classical" Primary
Neuropathic
Cardiopathic
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Therefore we believe that amyloid is in some way related pathogeneticaly to
the connective tissue and to the normal ribrous proteins — probably reticulin and
collagen. It is tempting to assume that amyloidosis is an aberration of those cells,
which in health form the normal fibrous proteins and go astray as the result of
some inborn or acquired defect and form amyloid. Of course, this is speculation
awaiting proof. We do believe, however, that the recognition of five clear-cut entities
of genetic amyloidosis will certainly be helpful in the concept and also in the final
elucidation of the pathogenesis of amyloidosis.
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